methylation
MTHFR Explained: What the Most-Hyped Variant Actually Means
rs1801133 affects how your body activates folate. Here's what 'compound heterozygous' really tells you about supplementation choices.
GenoSight Team · April 29, 2026 · 4 min read
If you want the shorter product path first, see GenoSight's MTHFR test from raw DNA data. It explains how an existing 23andMe, AncestryDNA, or MyHeritage file can be re-analyzed for MTHFR C677T and A1298C without ordering a new lab test.
If you've spent any time in the genetic-health corner of the internet, you've seen MTHFR. It's the variant that gets blamed for everything from miscarriage risk to anxiety to needing fancy supplements. Most of that is overhyped. Some of it is real. Here's the calm version — and how it fits into the broader picture of what GenoSight does with your raw DNA file.
What MTHFR actually does
MTHFR — methylenetetrahydrofolate reductase — is the enzyme that converts 5,10-methylene-THF into 5-methyl-THF, the form of folate your body uses to remethylate homocysteine into methionine. That methionine then donates methyl groups for everything from neurotransmitter synthesis to DNA methylation. Slow MTHFR → folate piles up in less-useful forms → the methylation cycle runs slower than it should.
Two variants matter clinically:
- C677T (rs1801133) — the most-studied. The T allele reduces enzyme activity in a temperature-sensitive way (about 30% reduction heterozygous, ~70% homozygous TT).
- A1298C (rs1801131) — milder in isolation but compounds with C677T.
The combinations that get attention:
| Genotype | C677T | A1298C | Approx. enzyme activity |
|---|---|---|---|
| Wild type | CC | AA | 100% |
| Single het | CT | AA | ~70% |
| Double het ("compound heterozygous") | CT | AC | ~50% |
| Homozygous T | TT | AA | ~30% |
What the chip can tell you
Both variants are typed directly by every consumer chip array (23andMe, AncestryDNA, MyHeritage). No imputation needed — the calls are direct reads.
What it does not mean
MTHFR variants are common. About 30–40% of people of European ancestry carry at least one C677T copy. If MTHFR were a major disease driver, half the population would be sick. It isn't.
Three frequently-claimed associations don't hold up under careful review:
- MTHFR doesn't cause depression. Effect sizes in well-powered GWAS are near-zero. Folate-cycle nutrient status (B12, B6, folate intake) explains much more variance.
- MTHFR doesn't require methylfolate. For most carriers, regular folate- rich diet meets demand. The exception: pregnancy, where higher demand + reduced enzyme activity makes activated folate (5-MTHF / methylfolate) the safer choice.
- MTHFR doesn't predict cardiovascular events independently of homocysteine. When homocysteine is in range (under 10 µmol/L), the genotype barely matters.
What it does mean — questions to raise with your clinician
Two areas that come up in the literature and are worth raising with a healthcare provider rather than acting on independently:
1. Homocysteine in the broader picture
The biomarker most often cited alongside MTHFR is homocysteine. Reference ranges and what to do about them are clinical decisions for a healthcare provider working with your full picture, not a consumer-genomics tool.
2. Folate form during pregnancy planning
For homozygous TT or compound heterozygous individuals, the literature discusses methylated folate forms (5-methyl-THF) versus synthetic folic acid. Specific dosing and form choice — particularly during pregnancy planning — should be made with a clinician who can integrate your medical history, prenatal-care plan, and labs.
For most people without a clinical reason to dig deeper, a folate-rich diet meets demand. Consult your healthcare provider before changing any supplementation.
How this looks in your DNA report
GenoSight's Nutrition report shows your C677T and A1298C calls alongside five other methylation SNPs (MTRR, MTR, BHMT, AHCY, COMT). The combination matters more than any single variant in the literature. The synthesis pulls your genotype, your reported supplement stack, and your stated goals into one paragraph that describes what the literature says about your variant profile in context — rather than a generic gene-by-gene table you'd have to interpret yourself. The output is educational, not a substitute for a clinical consultation.
Worth knowing first: a consumer chip array can read these variants directly, but it can't catch every clinically-relevant variant in the genome — so a clean MTHFR result doesn't rule out other methylation-pathway concerns that need a clinical-grade panel.
For the product path, compare the MTHFR raw DNA test, the MTHFR and COMT report, the broader raw DNA health report menu, the free DNA health report trial, and pricing and free credits.
See your MTHFR + the rest of your methylation cycle
Your Nutrition report shows all 7 methylation-relevant SNPs with the genotype calls from your raw DNA file.
If you want the broader methylation and nutrition context beyond one marker, choose monthly for 1,500 monthly credits, PDF exports, regenerations, and findings-grounded chat.
The takeaway
MTHFR is real, MTHFR is common, MTHFR is mostly fine. The internet noise around it is overhyped; the underlying biology is interesting but bounded.
If you take one thing away: variants are hypotheses, not actions. The clinical decisions — whether and how to test homocysteine, whether to change a B-vitamin form, whether any of it matters in your specific case — belong with a healthcare provider who can see your full picture.
Sources
- Frosst P et al. Nat Genet (1995). Original C677T characterization.
- van der Put NM et al. Am J Hum Genet (1998). A1298C characterization.
- NIH Office of Dietary Supplements — Folate Health Professional Fact Sheet.
- ClinVar — MTHFR variants.
